Flomenberg Neal
Known title: Chief Scientific OfficerCIK: 0002011757
Associated companies
Transaction History
| TVGN | ▼ Sell | Open Market | 501 | $3K | 3/13/2026 | View on chart |
| TVGN | ▼ Sell | Open Market | 452 | $3K | 3/11/2026 | View on chart |
| TVGN | ▼ Sell | Open Market | 19 | $147 | 3/10/2026 | View on chart |
| TVGN | ▲ Buy | Grant | 300,000 | $0 | 6/27/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 232,968 | $254K | 3/12/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 70,252 | $74K | 3/11/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 70,384 | $77K | 3/10/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 71,273 | $81K | 3/7/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 88,519 | $97K | 3/6/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 110,659 | $134K | 3/5/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 14,639 | $19K | 3/4/2025 | View on chart |
| TVGN | ▼ Sell | Open Market | 1,078,600 | $1.7M | 10/17/2024 | View on chart |
| TVGN | ▲ Buy | Grant | 5,332,902 | — | 2/14/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Tevogen Regains Nasdaq Listing Compliance
Tevogen Inc. has regained compliance with Nasdaq Global Market continued listing requirements. This development addresses potential delisting risks associated with the company's stock status. The news provides regulatory clarity for the ticker, which has seen significant price volatility over the past year.
Tevogen Regains Nasdaq Listing Compliance. Tevogen Inc. has regained compliance with Nasdaq Global Market continued listing requirements. This development addresses potential delisting risks associated with the company's stock status. The news provides regulatory clarity for the ticker, which has seen significant price volatility over the past year.